ISPED (Institut de Santé Publique, d'Epidémiologie et de Développement)
Bordeaux, 33076, France
NCT Number: NCT01081743
Context: The French Alzheimer plan 2008-2012 includes the implementation of "disease managers" or social workers, from the onset of the disease, for every patient with a diagnosis of Alzheimer disease or associated disorder. However, previous trials evaluating the efficacy of a systematic intervention for each case from the onset of the disease, including non complex cases, have shown little evidence.
Objective: To evaluate the efficacy of a social worker to prevent behavioural problem for patient with a new diagnosis of Alzheimer disease or associated disorder.
Design and setting: Multicentric cluster randomized control trial. Patients from several memory consultations and specialists (neurologist, psychiatrist or geriatrician) in France are included.
Intervention: In addition to usual care, patients in the intervention group have systematic home visits from a social worker and regular follow-ups by phone over a one-year period. This social worker informs the patient and caregiver, evaluates the needs, gives advices to prevent complications and is a link between the patient and the memory consultation or the specialist. Patient in the control group have absolutely no intervention and are followed-up as usually. In order to not modify the usual care, they have no information on their participation in this trial before the one-year evaluation.
Main outcome measure: NeuroPsychiatric Inventory (NPI) administrated at one year, which evaluates frequency, severity and repercussion of several behavioural problems. Secondary outcomes included disability, cognition, depression, health, quality of life, institutionalization, and resource use.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Bordeaux, 33076, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Systematic home visits and regular follow-ups by phone from a social worker
Time frame: 1 year
Evaluation of frequency, severity and repercussion of several behavioural problems
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Institut de Sante Publique, d'Epidemiologie et de Developpement
Other
Evaluation de la Mise en Place d'un Auxiliaire d'évaluation Dans la Prise en Charge de la Maladie d'Alzheimer et Des Maladies apparentées en France
Acronym: AIDALZ
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06850870
Alzheimer Disease, Alzheimer Disease or Associated Disorder
San Leandro, California, United States
View Trial DetailsNCT06860035
Alzheimer Disease, Alzheimer Disease or Associated Disorder
New York, United States
View Trial DetailsNCT06933849
Alzheimer Disease, Alzheimer Disease or Associated Disorder
Omaha, Nebraska, United States
View Trial DetailsNCT07465783
Alzheimer Disease, Alzheimer Disease or Associated Disorder
Saint-Etienne, France
View Trial Details